These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 10435570
1. Analysis of chromosome 22q as an aid to the diagnosis of rhabdoid tumor: a case report. Simons J, Teshima I, Zielenska M, Edwards V, Taylor G, Squire J, Thorner P. Am J Surg Pathol; 1999 Aug; 23(8):982-8. PubMed ID: 10435570 [Abstract] [Full Text] [Related]
2. Congenital disseminated malignant rhabdoid tumor: a distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11. White FV, Dehner LP, Belchis DA, Conard K, Davis MM, Stocker JT, Zuppan CW, Biegel JA, Perlman EJ. Am J Surg Pathol; 1999 Mar; 23(3):249-56. PubMed ID: 10078913 [Abstract] [Full Text] [Related]
3. Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22. Rosty C, Peter M, Zucman J, Validire P, Delattre O, Aurias A. Genes Chromosomes Cancer; 1998 Feb; 21(2):82-9. PubMed ID: 9491318 [Abstract] [Full Text] [Related]
4. Narrowing the critical region for a rhabdoid tumor locus in 22q11. Biegel JA, Allen CS, Kawasaki K, Shimizu N, Budarf ML, Bell CJ. Genes Chromosomes Cancer; 1996 Jun; 16(2):94-105. PubMed ID: 8818656 [Abstract] [Full Text] [Related]
5. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic? Fuller CE, Pfeifer J, Humphrey P, Bruch LA, Dehner LP, Perry A. Hum Pathol; 2001 Oct; 32(10):1102-8. PubMed ID: 11679945 [Abstract] [Full Text] [Related]
6. Malignant rhabdoid tumor of the kidney: involvement of chromosome 22. Shashi V, Lovell MA, von Kap-herr C, Waldron P, Golden WL. Genes Chromosomes Cancer; 1994 May; 10(1):49-54. PubMed ID: 7519873 [Abstract] [Full Text] [Related]
7. Atypical teratoid/rhabdoid tumor: cytology and differential diagnosis in adults. Raisanen J, Hatanpaa KJ, Mickey BE, White CL. Diagn Cytopathol; 2004 Jul; 31(1):60-3. PubMed ID: 15236268 [Abstract] [Full Text] [Related]
8. Atypical teratoid/rhabdoid tumor of the central nervous system: clinico-pathological study. Lee MC, Park SK, Lim JS, Jung S, Kim JH, Woo YJ, Lee JS, Kim HI, Jeong MJ, Choi HY. Neuropathology; 2002 Dec; 22(4):252-60. PubMed ID: 12564764 [Abstract] [Full Text] [Related]
9. High-density single nucleotide polymorphism array analysis in patients with germline deletions of 22q11.2 and malignant rhabdoid tumor. Jackson EM, Shaikh TH, Gururangan S, Jones MC, Malkin D, Nikkel SM, Zuppan CW, Wainwright LM, Zhang F, Biegel JA. Hum Genet; 2007 Sep; 122(2):117-27. PubMed ID: 17541642 [Abstract] [Full Text] [Related]
11. Establishment and molecular characterization of five cell lines derived from renal and extrarenal malignant rhabdoid tumors. Rosson GB, Hazen-Martin DJ, Biegel JA, Willingham MC, Garvin AJ, Oswald BW, Wainwright L, Brownlee NA, Wright CF. Mod Pathol; 1998 Dec; 11(12):1228-37. PubMed ID: 9872656 [Abstract] [Full Text] [Related]
12. A role for fluorescence in situ hybridization detection of chromosome 22q dosage in distinguishing atypical teratoid/rhabdoid tumors from medulloblastoma/central primitive neuroectodermal tumors. Bruch LA, Hill DA, Cai DX, Levy BK, Dehner LP, Perry A. Hum Pathol; 2001 Feb; 32(2):156-62. PubMed ID: 11230702 [Abstract] [Full Text] [Related]
13. Chromosome analyses in a rhabdoid tumor of the brain. Klopfenstein K, Soukup S, Blough R, Mazewski C, Ballard E, Gotwals B, Lampkin B. Cancer Genet Cytogenet; 1997 Feb; 93(2):152-6. PubMed ID: 9078300 [Abstract] [Full Text] [Related]
14. Immunohistochemical study as a tool in differential diagnosis of pediatric malignant rhabdoid tumor. Machado I, Noguera R, Santonja N, Donat J, Fernandez-Delgado R, Acevedo A, Baragaño M, Navarro S. Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):150-8. PubMed ID: 19770707 [Abstract] [Full Text] [Related]
15. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. Kuroda H, Moritake H, Sawada K, Kuwahara Y, Imoto I, Inazawa J, Sugimoto T. Cancer Genet Cytogenet; 2005 Apr 15; 158(2):172-9. PubMed ID: 15796965 [Abstract] [Full Text] [Related]
16. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Clin Cancer Res; 2002 Nov 15; 8(11):3461-7. PubMed ID: 12429635 [Abstract] [Full Text] [Related]
17. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. Rorke LB, Packer R, Biegel J. J Neurooncol; 1995 Nov 15; 24(1):21-8. PubMed ID: 8523069 [Abstract] [Full Text] [Related]
18. Frequent breakpoints of focal deletion and uniparental disomy in 22q11.1 or 11.2 segmental duplication region reveal distinct tumorigenesis in rhabdoid tumor of the kidney. Haruta M, Arai Y, Okita H, Tanaka Y, Takimoto T, Kamijo T, Oue T, Souzaki R, Taguchi T, Kuwahara Y, Chin M, Nakadate H, Hiyama E, Ishida Y, Koshinaga T, Kaneko Y. Genes Chromosomes Cancer; 2021 Aug 15; 60(8):546-558. PubMed ID: 33896058 [Abstract] [Full Text] [Related]
19. Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid/rhabdoid tumour. Beddow RA, Smith M, Kidd A, Corbett R, Hunter AG. Eur J Med Genet; 2011 Aug 15; 54(3):295-8. PubMed ID: 21187175 [Abstract] [Full Text] [Related]
20. Complex rearrangement of chromosomes 6 and 11 as the sole anomaly in atypical teratoid/rhabdoid tumors of the central nervous system. Lopez-Gines C, Cerda-Nicolas M, Kepes J, Donat J, Gil-Benso R, Llombart-Bosch A. Cancer Genet Cytogenet; 2000 Oct 15; 122(2):149-52. PubMed ID: 11106829 [Abstract] [Full Text] [Related] Page: [Next] [New Search]